MatthewEdmund BoydDixonMDFACS(He/Him)
General Surgery • Chicago, ILHepatobiliary Surgery, Pancreas, Surgical Oncology (Other than Breast)
Associate Professor of Surgery
Overview of Dr. Dixon
Dr. Matthew Dixon is a Hepatopancreatobiliary surgeon in Chicago, IL and is affiliated with Rush University Medical Center. He has a passion and interest in the clinical treatment of patients with cancers of the liver, metastatic disease of the liver (such as metastatic colorectal cancer), benign liver tumors, bile duct cancer, pancreatic cancer, pancreatic cysts, neuroendocrine tumors and other types of rare pancreatic tumors.
Office
1725 W Harrison St, Suite 810
Chicago, IL 60614Fax+1 312-563-2775
Education & Training
Maimonides Medical CenterResidency, Surgery, 2009 - 2014
St. George's University School of MedicineClass of 2009
Certifications & Licensure
IL State Medical License 2022 - 2026
IN State Medical License 2022 - 2025
PA State Medical License 2018 - 2023- American Board of Surgery Surgery
- American Board of Surgery Complex General Surgical Oncology
Publications & Presentations
PubMed
- 1 citationsPrediction of post-hepatectomy liver failure by preoperative gadoxetate disodium-enhanced magnetic resonance imaging.Johannes C Lauscher, Matthew E B Dixon, George Jada, Mariam Afshin, Konrad Neumann
HPB. 2024-06-01 - Gallbladder Cancer Incidentally Found at Cholecystectomy: Perioperative Risk Factors.Elizabeth J Olecki, Mackenzie Mayhew, Rolfy Perez Holguin, William G Wong, Kelly A Stahl
Journal of Gastrointestinal Cancer. 2024-06-01 - Total pancreatectomy, splenectomy and remnant gastrectomy for invasive intraductal papillary mucinous neoplasm (IPMN) after prior Roux-en-Y gastric bypass.Joanna T Buchheit, Isha Joshi, Matthew E Dixon, June S Peng
BMJ Case Reports. 2024-04-09
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
